Biotechnology
Company Overview of Protagenic Therapeutics Inc.
Company Overview
Protagenic Therapeutics Inc. is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Its products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. Protagenic Therapeutics Inc. was incorporated in 2004 and is based in New York, New York.
162 Fifth Avenue
Suite 900
New York, NY 10010
United States
Founded in 2004
Key Executives for Protagenic Therapeutics Inc.
Similar Private Companies By Industry
| Company Name | Region |
| Novartis Consumer Health, Inc. | United States |
| Amneal Pharmaceuticals of New York, LLC | United States |
| Nutra Med, Inc. | United States |
| Altermune Technologies LLC | United States |
| Becker Underwood Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Protagenic Therapeutics Inc., please visit www.protagenic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
